VLN Stock Analysis: Valens | NYSE
Semiconductors | NYSE, USA | Market Cap: 234m USD | 12M Return: -22.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.70M
Qual. Beats: 0
Rev. Trend: -57.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality
Valens Semiconductor Ltd. (NYSE: VLN) is an Israel-based designer of high-speed connectivity solutions for the audio-video and automotive sectors. The company’s core technology, HDBaseT, facilitates the transmission of ultra-high-definition video, audio, and power over a single cable, serving markets such as medical imaging and digital signage. In the automotive space, Valens focuses on MIPI A-PHY standards, which provide the high-bandwidth, low-latency data links required for advanced driver-assistance systems (ADAS).
The semiconductor industry is currently shifting toward standardized long-reach connectivity to support the increasing sensor density in autonomous vehicles. Valens utilizes a fabless business model, focusing on chip design and intellectual property while outsourcing the physical manufacturing process to specialized foundries. Investors can examine detailed valuation metrics and historical performance trends on ValueRay. The company distributes its VS and VA product series through a combination of direct sales and global distribution networks.
- Adoption of MIPI A-PHY standard accelerates automotive long-term revenue growth
- High interest rates dampen corporate spending on professional audio-video infrastructure
- Design wins with tier-one automotive suppliers drive future volume production
- Geopolitical instability in Israel poses potential disruption to core R&D operations
- Transition to high-speed USB extension chips expands total addressable market share
| Net Income: -31.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.09 > 0.02 and ΔFCF/TA -4.08 > 1.0 |
| NWC/Revenue: 129.2% < 20% (prev 189.8%; Δ -60.62% < -1%) |
| CFO/TA -0.08 > 3% & CFO -10.3m > Net Income -31.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 5.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.0m) vs 12m ago -0.20% < -2% |
| Gross Margin: 62.26% > 18% (prev 60.26%; Δ 1.99% > 0.5%) |
| Asset Turnover: 49.94% > 50% (prev 40.84%; Δ 9.09% > 0%) |
| Interest Coverage Ratio: -298.5 > 6 (EBIT TTM -32.5m / Interest Expense TTM 109k) |
| A: 0.71 (Total Current Assets 113.0m - Total Current Liabilities 21.7m) / Total Assets 128.4m |
| B: -1.98 (Retained Earnings -253.8m / Total Assets 128.4m) |
| C: -0.23 (EBIT TTM -32.5m / Avg Total Assets 141.5m) |
| D: 3.56 (Book Value of Equity 100.2m / Total Liabilities 28.2m) |
| Altman-Z'' = 0.41 = B |
| DSRI: 0.98 (Receivables 10.5m/9.55m, Revenue 70.7m/63.1m) |
| GMI: 0.97 (GM 60.26% / 62.26%) |
| AQI: 1.02 (AQ_t 0.05 / AQ_t-1 0.05) |
| SGI: 1.12 (Revenue 70.7m / 63.1m) |
| TATA: -0.17 (NI -31.6m - CFO -10.3m) / TA 128.4m) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of July 06, 2026, the stock is trading at USD 2.07 with a total of 1,807,700 shares traded. Over the past week, the price has changed by +1.47%, over one month by -1.90%, over three months by +73.95% and over the past year by -22.76%.
Current recommended Stop Loss: 1.50 (which is 27.5% or 2.2 ATR below the current price).
Valens has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy VLN.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4.3 | 109.2% |
P/E Forward = 60.6061
P/S = 3.31
P/B = 2.4087
Revenue TTM = 70.7m USD
EBIT TTM = -32.5m USD
EBITDA TTM = -29.4m USD
Long Term Debt = 6.39m USD (estimated: total debt 7.98m - short term 1.59m)
Short Term Debt = 1.59m USD (from shortTermDebt, last quarter)
Debt = 7.98m USD (from shortLongTermDebtTotal, last quarter) (leases 7.98m already included)
Net Debt = -79.3m USD (calculated: Debt 7.98m - CCE 87.3m)
Enterprise Value = 154.6m USD (233.9m + Debt 7.98m - CCE 87.3m)
Interest Coverage Ratio = -298.5 (Ebit TTM -32.5m / Interest Expense TTM 109k)
EV/FCF = -13.57x (Enterprise Value 154.6m / FCF TTM -11.4m)
FCF Yield = -7.37% (FCF TTM -11.4m / Enterprise Value 154.6m)
FCF Margin = -16.12% (FCF TTM -11.4m / Revenue TTM 70.7m)
Net Margin = -44.67% (Net Income TTM -31.6m / Revenue TTM 70.7m)
Gross Margin = 62.26% ((Revenue TTM 70.7m - Cost of Revenue TTM 26.7m) / Revenue TTM)
Gross Margin QoQ = 62.20% (prev 60.54%)
Tobins Q-Ratio = 1.20 (Enterprise Value 154.6m / Total Assets 128.4m)
Interest Expense / Debt = 1.37% (Interest Expense 109k / Debt 7.98m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -25.7m (EBIT -32.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.21 (Total Current Assets 113.0m / Total Current Liabilities 21.7m)
Debt / Equity = 0.08 (Debt 7.98m / totalStockholderEquity, last quarter 100.2m)
Debt / EBITDA = 2.70 (negative EBITDA) (Net Debt -79.3m / EBITDA -29.4m)
Debt / FCF = 6.96 (negative FCF - burning cash) (Net Debt -79.3m / FCF TTM -11.4m)
Total Stockholder Equity = 107.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -22.31% (Net Income -31.6m / Total Assets 128.4m)
RoE = -29.33% (Net Income TTM -31.6m / Total Stockholder Equity 107.6m)
RoCE = -28.53% (EBIT -32.5m / Capital Employed (Equity 107.6m + L.T.Debt 6.39m))
RoIC = -24.53% (negative operating profit) (NOPAT -25.7m / Invested Capital 104.8m)
WACC = 12.00% (E(233.9m)/V(241.8m) * Re(12.37%) + D(7.98m)/V(241.8m) * Rd(1.37%) * (1-Tc(0.21)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -11.11 | Cagr: 0.89%
[DCF] Fair Price = unknown (Cash Flow -11.4m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.34 | # QB: 0
Revenue Correlation: -57.84 | Revenue CAGR: -9.12% | SUE: 0.70 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.04 | Chg30d=+15.79% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=-0.03 | Chg30d=N/A | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=-0.13 | Chg30d=+21.59% | Revisions=+17% | GrowthEPS=+4.8% | GrowthRev=+7.0%
EPS next Year (2027-12-31): EPS=-0.08 | Chg30d=+35.92% | Revisions=+40% | GrowthEPS=+37.5% | GrowthRev=+19.4%
[Analyst] Revisions Ratio: +25% (up=6, down=3)